Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) EBT Margin (2022 - 2025)

Historic EBT Margin for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to 164.92%.

  • Centessa Pharmaceuticals' EBT Margin changed N/A to 164.92% in Q1 2025 from the same period last year, while for Sep 2025 it was 1595.38%, marking a year-over-year decrease of 77559600.0%. This contributed to the annual value of 2570.28% for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Centessa Pharmaceuticals' EBT Margin is 164.92%.
  • Centessa Pharmaceuticals' 5-year EBT Margin high stood at 3913.07% for Q2 2022, and its period low was 164.92% during Q1 2025.
  • Its 3-year average for EBT Margin is 2147.61%, with a median of 1997.43% in 2023.
  • Data for Centessa Pharmaceuticals' EBT Margin shows a peak YoY increase of -6010400bps (in 2023) and a maximum YoY decrease of -19156400bps (in 2023) over the last 5 years.
  • Over the past 3 years, Centessa Pharmaceuticals' EBT Margin (Quarter) stood at 1989.88% in 2022, then plummeted by -30bps to 1388.83% in 2023, then plummeted by -112bps to 164.92% in 2025.
  • Its last three reported values are 164.92% in Q1 2025, 1388.83% for Q4 2023, and 1632.19% during Q3 2023.